Purple Innovation's third quarter was a clear step backward for a turnaround that had already been losing altitude. The company posted an adjusted loss of $2.41 per share, far worse than the $0.72 loss consensus expected, a 234.7% miss, and 20.5% worse than a year ago. Revenue fell 18.7% to $96.5 million and missed the $108.1 million consensus by 10.8%. The more consequential development was the trajectory. Revenue declines accelerated sharply from -8.1% in Q1 and -6.5% in Q2 to roughly -19%. Management also cut full-year adjusted EBITDA guidance for the second time, to $15-20 million from $20-25 million. That cut came even as it held revenue guidance at $420-440 million. That is the central tension: a company running out of runway on its balance sheet is now asking investors to underwrite a big fourth quarter and a 2027 product reset.
The headline GAAP figures flatter the quarter. The GAAP net loss narrowed to $1.4 million, or $0.33 per diluted share, from $11.7 million. However, that improvement rests largely on a $14.3 million non-cash gain from the change in fair value of warrant liabilities. Strip that out, along with other items, and the adjusted net loss widened to $10.5 million from $8.6 million. Gross margin fell 410 basis points to 43.4%, down from 45.2% in Q2 and below the roughly 45% full-year target. Management blamed lower production leverage and inventory adjustments. Adjusted EBITDA swung to a $0.5 million loss from a $2.1 million profit in Q2. Operating expenses fell 25% to $51.7 million, a genuine accomplishment, but cost cuts are not keeping pace with lost volume.
Wholesale is where the business broke down. Revenue in the channel fell to $35.6 million from $51.5 million, a 31% decline. About a quarter of that drop reflected higher payments to customers that are booked as revenue reductions, and the underlying decline was roughly 23%. That compares with about -8% underlying in Q2 and +1% in Q1. Purple is losing slots, customers and velocity at regional and independent retailers, and the CEO conceded the product line is "tired." Direct-to-consumer also weakened. Showroom sales fell 16%, ending a four-quarter growth streak, as the June 8-10% price increase hit demand harder than expected. Management also trimmed its 2027 showroom opening target to 9-12 from 12-16. There was one encouraging thread. DTC was up 1% and e-commerce up 2% in August and September, helped by better conversion on Purple.com and Amazon, even as the category declined at a mid-to-high single-digit rate.
The forward story now hinges on execution in a narrow window. The reaffirmed revenue range implies fourth-quarter sales of roughly $130-150 million against $290.5 million through nine months. The EBITDA guide implies a sharply profitable Q4 after a cumulative adjusted EBITDA loss of $3.3 million year to date. Management is leaning on several supports to get there:
- seasonal DTC strength;
- a wholesale price increase flowing through fully;
- a Costco holiday mattress and pillow launch;
- an HQ sublet.
Beyond that sits the largest product refresh in company history: new Essentials and Hybrid collections covering almost 90% of mattress unit volume, plus the first redesign of the GelFlex Grid. Management is targeting gross margin "well north of 45%" as volume returns, but that is an aspiration, not a result.
The balance sheet makes the timeline unforgiving. The $135.1 million of related-party debt is now classified as current, with maturity in April 2027. No refinancing plan has been disclosed, a going-concern qualification remains outstanding, and the strategic alternatives review continues. The stockholders' deficit widened to $65.2 million. Positive operating cash flow for a third straight quarter is real, with $10.6 million year to date and cash up to $28.3 million. But much of that came from a $29.7 million reduction in receivables rather than operating earnings, and interest expense still runs about $8 million a quarter, much of it paid in kind.
The market had already priced in considerable distress. Shares fell 66.4% from the $7.51 open after the August report to $2.52. They sit 75.6% below the 200-day moving average and hit a 52-week low of $1.83 on October 8 before rebounding about 38%. Investor sentiment improved substantially ahead of the report, moving from -0.49 to roughly neutral at +0.02. That likely reflects a sense that the worst was priced in, but this quarter's guidance cut and wholesale deterioration test that thesis. The internal trend readings remain mostly negative, with momentum and AVWAP still weak.
The bottom line is that Purple delivered a deep miss, accelerating revenue declines and a second EBITDA guidance cut. The redeeming points, cost discipline, steady cash generation, a late-quarter DTC uptick and an ambitious 2027 refresh, do not address the core problem. The new products arrive around the same time the debt comes due. Until refinancing is resolved and wholesale stabilizes, bears have legitimate ammunition, and the low share price reflects existential questions rather than an obvious bargain.